Par Pharmaceutical sued for patent infringement

21-11-2016

Par Pharmaceutical sued for patent infringement

BrAt82 / shutterstock.com

Biotech company United Therapeutics Corporation has filed a complaint against US-based Par Pharmaceutical for infringement of patents covering Remodulin (treprostinil sodium).


Par Pharmaceutical, patent, patent infringement, United Therapeutics Corporation, Remodulin, ANDA

LSIPR